Amgen (NASDAQ: AMGN) reported Q4 EPS of $5.31, $0.27 better than the analyst estimate of $5.04. Revenue for the quarter came in at $9.1 billion versus the consensus estimate of $8.85 billion.

GUIDANCE:

Amgen sees FY2025 EPS of $20.00-$21.20, versus the consensus of $20.82.

For earnings history and earnings-related data on Amgen (AMGN) click here.